Instituto de Química, Universidade de São Paulo, CP 26077, 05513-970 São Paulo, SP, Brazil.
Phys Chem Chem Phys. 2011 Sep 7;13(33):14946-52. doi: 10.1039/c1cp21525f. Epub 2011 Jul 19.
The entrapment of hematoporphyrin IX (Hp IX) in silica by means of a microemulsion resulted in silica spheres of 33 ± 6 nm. The small size, narrow size distribution and lack of aggregation maintain Hp IX silica nanospheres stable in aqueous solutions for long periods and permit a detailed study of the entrapped drug by different techniques. Hp IX entrapped in the silica matrix is accessed by oxygen and upon irradiation generates singlet oxygen which diffuses very efficiently to the outside solution. The Hp IX entrapped in the silica matrix is also reached by iron(II) ions, which causes quenching of the porphyrin fluorescence emission. The silica matrix also provides extra protection to the photosensitizer against interaction with BSA and ascorbic acid, which are known to cause suppression of singlet oxygen generation by the Hp IX free in solution. Therefore, the incorporation of Hp IX molecules into silica nanospheres increased the potential of the photosensitizer to perform photodynamic therapy.
血卟啉 IX(HpIX)通过微乳液被包埋在二氧化硅中,形成了 33±6nm 的二氧化硅小球。这些小球具有较小的尺寸、较窄的尺寸分布和缺乏聚集的特点,从而使得 HpIX 二氧化硅纳米球在水溶液中能够长时间保持稳定,并允许通过不同的技术对包埋药物进行详细研究。包埋在二氧化硅基质中的 HpIX 可以与氧气接触,在光照下会产生单线态氧,该物质可以非常有效地扩散到外部溶液中。包埋在二氧化硅基质中的 HpIX 也可以与二价铁离子接触,这会导致卟啉荧光发射的猝灭。二氧化硅基质还为光敏剂提供了额外的保护,使其免受与 BSA 和抗坏血酸的相互作用,因为已知 BSA 和抗坏血酸会抑制游离于溶液中的 HpIX 产生单线态氧。因此,将 HpIX 分子掺入二氧化硅纳米球中增加了光敏剂进行光动力疗法的潜力。